Cell-based Non-invasive Prenatal Test Workflow

Starting soon

Conditions studied: Pregnant Women

In brief

The aim of this study is to optimize a new non-invasive prenatal screening method based on the capture of fetal cells from maternal blood and to complete its development by obtaining maternal blood samples during the first trimester of pregnancy.

Key facts

Study ID

NCT07566780

Run by

Menarini Silicon Biosystems

People needed

1400

Starts

2026-05-04

Expected to finish

2027-12-31

Last updated by the study team

2026-05-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Informed consent signed before any study-specific procedures
• Pregnant women with singleton or twin pregnancy, at 8+0 - 14+6 week of gestation, aged ≥18 years
• No medical contraindication for collecting 30 ml blood sample

You may not qualify if…

• Unable to provide informed consent
• Known infections that carry a risk of vertical transmission
• Known maternal viral diseases: HIV and HCV, HBV

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.